SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-240385
Filing Date
2013-05-30
Accepted
2013-05-30 07:43:26
Documents
9
Period of Report
2013-05-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d546634d8k.htm 8-K 16082
2 EX-99.1 d546634dex991.htm EX-99.1 30909
3 GRAPHIC g546634img01.jpg GRAPHIC 107434
4 GRAPHIC g546634img02.jpg GRAPHIC 277990
5 GRAPHIC g546634img04.jpg GRAPHIC 104591
6 GRAPHIC g546634img06.jpg GRAPHIC 249745
7 GRAPHIC g546634img07.jpg GRAPHIC 199105
8 GRAPHIC g546634img33.jpg GRAPHIC 212039
9 GRAPHIC g546634img55.jpg GRAPHIC 287138
  Complete submission text file 0001193125-13-240385.txt   2030645
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 13879910
SIC: 2834 Pharmaceutical Preparations